$38.43
+3.34 (+9.52%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-28.28%
1Y
+77.51%
YTD
-20.96%
Open$35.97
Previous Close$35.09
Day High$38.67
Day Low$35.95
52W High$56.05
52W Low$19.07
Volume—
Avg Volume1.03M
Market Cap2.52B
P/E Ratio—
EPS$-5.54
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$46.91
Below
SMA 200
$30.68
Above
RSI (14)
41.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+146.2% upside
Current
$38.43
$38.43
Target
$94.61
$94.61
$72.50
$94.61 avg
$144.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 672.08M | 640.49M | 736.20M |
| Net Income | -5,512,106 | -4,610,660 | -5,991,019 |
| Profit Margin | -0.8% | -0.7% | -0.8% |
| EBITDA | -7,633,568 | -6,751,763 | -9,172,286 |
| Free Cash Flow | -4,482,853 | -2,925,974 | -4,789,156 |
| Rev Growth | +20.0% | +11.6% | +0.9% |
| Debt/Equity | 0.79 | 0.70 | 0.90 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |